Camber Spine Continues to Add to Its “All Angles” Product Portfolio with Latest Patent Approval
Camber Spine Product Portfolio and Focus Sessions to be Presented at AANS KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--#AANS--Camber Spine, a leading...
Month: April 2022
Cell MedX Corp. Appoints Mr. Dwayne Yaretz as CEO and Director
Carson City, Nevada--(Newsfile Corp. - April 27, 2022) - Cell MedX Corp. (OTCQB: CMXC) ("Cell MedX" or the "Company"), a...
Corent and IBM Red Hat Achieve Finalist Status for “Best Platform as a Service” in the CODiE Awards
ALISO VIEJO, Calif.--(BUSINESS WIRE)--#CODiE--Corent Technology congratulates the teams at Corent and IBM Red Hat who reached Finalist Status in the...
Cloud DX Signs Clinic in Illinois Strengthening Position in the US
Cloud DX Signs Clinic in Illinois Strengthening Position in the USGrowing its partnership, Cloud DX welcomes the sixth Maxwell clinic...
Jaguar Animal Health Announces Commercial Availability of Plant-based Canalevia-CA1 (Crofelemer) Prescription Drug for the Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
Canalevia®-CA1 is the first and only treatment for CID in dogs to receive any type of approval from FDASAN FRANCISCO,...
Proxima Clinical Research Honored by Hermes Creative Awards
Proxima CRO recognized with two platinum awards, two gold awards, and five honorable mentions for its creative branding, marketing, and...
Arpa Garay Joins Moderna as Chief Commercial Officer
CAMBRIDGE, MA / ACCESSWIRE / April 27, 2022 / Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics...
Jupiter Wellness to Offer Clinical Research Services with Acquisition of Ascent Clinical Research: $3 Million Annual Revenue & EBITDA Contribution to Jupiter
IN A BID TO EXPAND JUPITER WELLNESS'S RESEARCH CAPABILITIES AND ENTER THE LUCRATIVE CRO BUSINESS, JUPITER WELLNESS ACQUIRED THE ASSETS...
Amarantus Signs Non-Binding Term Sheet to Divest Cutanogen Corporation in Exchange for the Extinguishment of Potential $21M+ in Liabilities
Board Member/Acting CEO Provides Shareholder UpdateSale of Engineered Skin Substitute (ESS) subsidiary, Cutanogen Corporation.Emphasis placed on advancing Elto Pharma, Inc....
NeoGenomics Reports Revenue of $117 Million in the First Quarter
First-Quarter 2022 ResultsConsolidated revenue increased 1% to $117 million; excluding 2021 COVID-19 PCR testing revenue, consolidated revenue increased 3%Clinical Services...
Zomedica to Present at H.C. Wainwright Global Investment Conference
ANN ARBOR, MI / ACCESSWIRE / April 27, 2022 / Zomedica Corp. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics...
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc., to Present SP-102 (SEMDEXA™) Efficacy and Safety Data from its Pivotal Phase 3 Clinical Trial Program for Sciatica Pain Management at the 24th Annual Meeting of American Society of Interventional Pain Physicians (ASIPP) in Las Vegas, NV.
PALO ALTO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company (“Scilex”), a nearly 100% (or over 99.9%) majority-owned...
AXIM Develops Quantitative Rapid Diagnostic Test for Lacritin; Now Boasts Four Dry Eye Disease Point-of-Care Biomarker Tests
SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare...
Truepill Names Doreen Bortel as Chief Growth Officer
SAN MATEO, Calif., April 27, 2022 (GLOBE NEWSWIRE) -- Truepill, the digital health platform connecting telehealth, diagnostics, and pharmacy infrastructure...
Michael Hammond Appointed to the Healthmap Solutions Board of Directors
Health System Industry Veteran Joins Healthmap Solutions Board as Need for Kidney Health Management Solutions SurgesTAMPA, Fla., April 27, 2022...
Alliance for Regenerative Medicine Announces CEO Transition
CEO to step down after leading ARM through period of tremendous growth; New Officer Roles AnnouncedWashington, DC, April 27, 2022...
Rakovina Therapeutics Inc. Announces 2021 Financial Results and Provides Corporate Update
VANCOUVER, British Columbia, April 27, 2022 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV, the “Company”) a biopharmaceutical company committed...
1Life Healthcare (One Medical) Announces Date of its First Quarter 2022 Results Conference Call
SAN FRANCISCO, April 27, 2022 (GLOBE NEWSWIRE) -- 1Life Healthcare, Inc. (One Medical) (Nasdaq: ONEM) today announced that its first...
Allied Corp Announces Initial US$147,000 Purchase Order Continuing into Monthly Supply Agreement for Brazilian Specialty Cancer Care Hospital
KELOWNA, British Columbia, April 27, 2022 (GLOBE NEWSWIRE) -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to...
Vir Biotechnology Announces New Data From the MARCH Hepatitis B Trial, Unveils New Hepatitis D Clinical Program and Highlights Broad Hepatitis Portfolio at Virtual Hepatitis Portfolio R&D Day
– Strategic clinical program for hepatitis B and D with potential for multiple value drivers in 2022 – – Virtual R&D...